Tarsons Products — 360° view

Tarsons Products, a company in the Medical Equipment & Supplies industry, reported revenue of ₹124 crore and a net loss of ₹0.34 crore for the September 2026 quarter.

Tarsons Products (NSE: TARSONS) closed at ₹303.40 on 20 Nov 2026, up 37.4% over the past year. Its market capitalisation is ₹1,614 crore and it trades at 197.3 times earnings.

Share price
₹303.40 (20 Nov 2026)
Market cap
₹1,614 Cr (20 Nov 2026)
P/E
197.34 (20 Nov 2026)
Revenue
₹124 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
4.59% (FY26)
ROE
2.44% (FY26)
Book value
₹119 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹375.00 / ₹164.45 (20 Nov 2026)
1-year return
37.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
NSE: TARSONS

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.